The proposed rule from the Food and Drug Administration comes in the final days of President ... but a similar effort led by Trump's first FDA commissioner, Dr. Scott Gottlieb, was sidelined during his first term. Trump's health secretary nominee, Robert ...
The FDA's proposed rule would slash nicotine levels in cigarettes, most cigars and other combustible tobacco products, but not vapes, hookahs or Zyn.
On its way out the door, the Biden administration has proposed a rule that would effectively ban cigarettes by requiring a drastic reduction in nicotine
Zeller credited Gottlieb for advocating for the nicotine regulation within the Trump White House, after the Obama administration had fallen short. Obama officials had promised Zeller they would back rules to curb nicotine and menthol.
The FDA is proposing a new rule that that would limit nicotine levels in cigarettes and other tobacco products.
The Biden administration's Food and Drug Administration (FDA) released additional details on a proposed rule that would effectively ban cigarettes currently on the market.
Nicotine levels in cigarettes sold in the U.S. would have to be drastically lowered under a proposal released Wednesday by the Food and ... Dr. Scott Gottlieb, who served as FDA commissioner during the first Trump administration, said the FDA proposal ...
On Wednesday the Food and Drug Administration published a proposed rule that would slash the amount of nicotine allowed in cigarettes and certain finished tobacco products.
First recommended by a Trump-appointed FDA leader, multiple administrations have collaborated to snuff out this issue that costs the country $600 billion annually.
A front-of-package food label would be a great educational tool. The Trump administration should keep it.
For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments to desperate patients looking for cures of intractable diseases and conditions such as Alzheimer’s,
New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain around insurance coverage and generative AI.